X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Torrent Pharma Fact Sheet, Torrent Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Fact Sheet   (TORR)

Here is the latest financial fact sheet of Torrent Pharma. For more details, see the Torrent Pharma quarterly results and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

TORRENT PHARMA Price History

Price Rs 1,440.7
Mkt Cap Rs m 243,844
Vol '000 5.7
P/E X 36.0
P/CF X 19.7
EPS (TTM) Rs 40.1
% ch % -0.8
No. of shares m 169.26
% ch week % -1.3
% ch 1-mth % -2.8
% ch 12-mth % 11.2
52 week H/L Rs 1,527.0/1,149.1
(As on Jul 18, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TORRENT PHARMA Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
TORRENT PHARMA EQUITY SHARE DATA
High Rs7675781,2321,7201,768 
Low Rs5973345231,1341,186 
Sales per share (Unadj.) Rs379.5247.3275.0394.5346.1 
Earnings per share (Unadj.) Rs51.139.244.4102.455.2 
Diluted earnings per shareRs25.639.244.4102.455.2 
Cash flow per share (Unadj.) Rs60.944.455.6116.573.3 
Dividends per share (Unadj.) Rs23.0010.0011.2540.0014.00 
Adj. dividends per shareRs11.5010.0011.2539.9914.00 
Dividend yield (eoy) %3.42.21.32.80.9 
Book value per share (Unadj.) Rs168.1112.4156.2206.5257.1 
Adj. book value per shareRs84.0112.4156.1206.4257.0 
Shares outstanding (eoy) m84.61169.22169.22169.22169.22 
Bonus/Rights/Conversions  -B1:1--- 
Price / Sales ratio x1.81.83.23.64.3 
Avg P/E ratio x13.311.619.813.926.8 
P/CF ratio (eoy) x11.210.315.812.320.1 
Price / Book Value ratio x4.14.15.66.95.7 
Dividend payout %45.025.525.439.125.4 
Avg Mkt Cap Rs m57,70477,190148,465241,435249,887 
No. of employees `0009.69.511.010.911.8 
Total wages/salary Rs m6,2337,4118,4188,4249,934 
Avg. sales/employee Rs Th3,354.04,386.54,212.46,129.64,971.5 
Avg. wages/employee Rs Th651.0776.8762.0773.4843.2 
Avg. net profit/employee Rs Th452.0695.9679.81,591.3792.4 
TORRENT PHARMA INCOME DATA
Net Sales Rs m32,11141,84746,53566,76458,569 
Other income Rs m4343812,8562,2562,233 
Total revenues Rs m32,54542,22949,39069,02060,802 
Gross profit Rs m6,9229,51510,20227,33013,773 
Depreciation Rs m8278701,9072,3763,069 
Interest Rs m3385861,7521,8402,056 
Profit before tax Rs m6,1918,4409,39825,37110,881 
Minority Interest Rs m-220000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-37500-1,9360 
Tax Rs m1,4671,8011,8886,1021,545 
Profit after tax Rs m4,3286,6397,50917,3339,336 
Gross profit margin %21.622.721.940.923.5 
Effective tax rate %23.721.320.124.114.2 
Net profit margin %13.515.916.126.015.9 
TORRENT PHARMA BALANCE SHEET DATA
Current assets Rs m25,60934,04540,98346,88253,841 
Current liabilities Rs m17,10721,74627,04632,85531,612 
Net working cap to sales %26.529.430.021.038.0 
Current ratio x1.51.61.51.41.7 
Inventory Days Days10588847497 
Debtors Days Days78961257984 
Net fixed assets Rs m11,05114,09534,72039,00742,079 
Share capital Rs m423846846846846 
"Free" reserves Rs m13,63417,27225,58334,09542,655 
Net worth Rs m14,21919,02426,43034,94143,501 
Long term debt Rs m4,5457,44521,72918,50122,408 
Total assets Rs m37,83950,69879,64190,579101,250 
Interest coverage x19.315.46.414.86.3 
Debt to equity ratio x0.30.40.80.50.5 
Sales to assets ratio x0.80.80.60.70.6 
Return on assets %12.314.311.621.211.3 
Return on equity %30.434.928.449.621.5 
Return on capital %32.734.123.247.319.6 
Exports to sales %37.737.430.443.30 
Imports to sales %7.68.26.06.90 
Exports (fob) Rs m12,11415,66514,13628,9340 
Imports (cif) Rs m2,4333,4162,8014,5840 
Fx inflow Rs m13,22816,86214,26529,18520,066 
Fx outflow Rs m4,7345,1965,1846,0215,304 
Net fx Rs m8,49411,6669,08123,16514,762 
TORRENT PHARMA CASH FLOW
From Operations Rs m 1,535 5,994 8,102 27,421 10,127 
From Investments Rs m -2,417 -3,558 -21,623 -8,379 -7,869 
From Financial Activity Rs m 197 864 12,123 -14,352 -1,918 
Net Cashflow Rs m -685 3,300 -1,399 4,375 212 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 71.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 7.0%
FIIs 12.6%
ADR/GDR 0.0%
Free float 8.8%
Shareholders 26,511
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Torrent House, Off Ashram Road, Ahmedabad - 380 009
E-MAIL maheshagrawal@torrentpharma.com WEB www.torrentpharma.com
TELEPHONE (079) 2658 5090 FAX (079) 2658 2100
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Sudhir Mehta COMP SEC: Mahesh Agarwal YEAR OF INC: 1973 BSE CODE: 500420 FV (Rs): 5 DIV YIELD (%): 1.0

More Pharmaceuticals Company Fact Sheets:   WYETH LTD  TTK HEALTHCARE  ORCHID PHARMA LTD  ALKEM LABORATORIES  SUVEN LIFE  

Compare TORRENT PHARMA With:   WYETH LTD  TTK HEALTHCARE  ORCHID PHARMA LTD  ALKEM LABORATORIES  SUVEN LIFE  

Compare TORRENT PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Lower; Tata Steel & Vedanta Top Losers(Closing)

Indian share markets erased early gains to end lower today, as the opposition parties tabled a no-confidence motion against Prime Minister Narendra Modi's government.

Views on news

TORRENT PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 10.7% (Quarterly Result Update)

Jun 1, 2018 | Updated on Jun 1, 2018

For the quarter ended March 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 10.7% YoY). Sales on the other hand came in at Rs 17 bn (up 20.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - NOVARTIS COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS